Back to Search Start Over

Attenuated PDGF signaling drives alveolar and microvascular defects in neonatal chronic lung disease.

Authors :
Oak P
Pritzke T
Thiel I
Koschlig M
Mous DS
Windhorst A
Jain N
Eickelberg O
Foerster K
Schulze A
Goepel W
Reicherzer T
Ehrhardt H
Rottier RJ
Ahnert P
Gortner L
Desai TJ
Hilgendorff A
Source :
EMBO molecular medicine [EMBO Mol Med] 2017 Nov; Vol. 9 (11), pp. 1504-1520.
Publication Year :
2017

Abstract

Neonatal chronic lung disease (nCLD) affects a significant number of neonates receiving mechanical ventilation with oxygen-rich gas (MV-O <subscript>2</subscript> ). Regardless, the primary molecular driver of the disease remains elusive. We discover significant enrichment for SNPs in the PDGF-Rα gene in preterms with nCLD and directly test the effect of PDGF-Rα haploinsufficiency on the development of nCLD using a preclinical mouse model of MV-O <subscript>2</subscript> In the context of MV-O <subscript>2</subscript> , attenuated PDGF signaling independently contributes to defective septation and endothelial cell apoptosis stemming from a PDGF-Rα-dependent reduction in lung VEGF-A. TGF-β contributes to the PDGF-Rα-dependent decrease in myofibroblast function. Remarkably, endotracheal treatment with exogenous PDGF-A rescues both the lung defects in haploinsufficient mice undergoing MV-O <subscript>2</subscript> Overall, our results establish attenuated PDGF signaling as an important driver of nCLD pathology with provision of PDGF-A as a protective strategy for newborns undergoing MV-O <subscript>2</subscript> .<br /> (© 2017 Helmholtz Zentrum München Published under the terms of the CC BY 4.0 license.)

Details

Language :
English
ISSN :
1757-4684
Volume :
9
Issue :
11
Database :
MEDLINE
Journal :
EMBO molecular medicine
Publication Type :
Academic Journal
Accession number :
28923828
Full Text :
https://doi.org/10.15252/emmm.201607308